Mast cells (MCs) are major effector cells of allergic reactions and contribute to multiple other pathophysiological processes. MCs are long-lived in the tissue microenvironment, in which they matured, but it remains ill-defined how longevity is established by the natural habitat, as research on human MCs chiefly employs cells generated and expanded in culture. In this study, we report that naturally differentiated skin MCs exhibit substantial resilience to cell death with considerable portions surviving up to 3 days in the complete absence of growth factors (GF). This was evidenced by kinetic resolution of membrane alterations (Annexin-V, YoPro), DNA degradation (propidium iodide), mitochondrial membrane disruption (Depsipher), and Caspase-3 activity. Because of the high basal survival, further protection by SCF was modest. Conversely, survival was severely compromised by staurosporine, implying functional caspase machinery. Contrary to the resistance of freshly purified MCs, their culture-expanded counterpart readily underwent cell death upon GF deprivation. Searching for the molecular underpinnings explaining the difference, we identified Mcl-1 as a critical protector. In fact, silencing Mcl-1 by RNAi led to impaired survival in skin MCs ex vivo, but not their cultured equivalent. Therefore, MCs matured in the skin have not only higher expression of Mcl-1 than proliferating MCs, but also greater reliance on Mcl-1 for their survival. Collectively, we report that human skin MCs display low susceptibility to cell death through vast expression of Mcl-1, which protects from mortality and may contribute to MC longevity in the tissue.
Mast cells (MCs) are major effector cells of allergic reactions and contribute to multiple other pathophysiological processes. MCs are long-lived in the tissue microenvironment, in which they matured, but it remains ill-defined how longevity is established by the natural habitat, as research on human MCs chiefly employs cells generated and expanded in culture. In this study, we report that naturally differentiated skin MCs exhibit substantial resilience to cell death with considerable portions surviving up to 3 days in the complete absence of growth factors (GF). This was evidenced by kinetic resolution of membrane alterations (Annexin-V, YoPro), DNA degradation (propidium iodide), mitochondrial membrane disruption (Depsipher), and Caspase-3 activity. Because of the high basal survival, further protection by SCF was modest. Conversely, survival was severely compromised by staurosporine, implying functional caspase machinery. Contrary to the resistance of freshly purified MCs, their culture-expanded counterpart readily underwent cell death upon GF deprivation. Searching for the molecular underpinnings explaining the difference, we identified Mcl-1 as a critical protector. In fact, silencing Mcl-1 by RNAi led to impaired survival in skin MCs ex vivo, but not their cultured equivalent. Therefore, MCs matured in the skin have not only higher expression of Mcl-1 than proliferating MCs, but also greater reliance on Mcl-1 for their survival. Collectively, we report that human skin MCs display low susceptibility to cell death through vast expression of Mcl-1, which protects from mortality and may contribute to MC longevity in the tissue.
Mast cells (MCs), strategically located at the interfaces of host and environment, are
primary effector cells of IgE-mediated allergic reactions, and thereby contribute to
allergic rhinoconjunctivitis, asthma, eczema, urticaria, and in the most severe case,
anaphylaxis.[1,2,3]In the skin, MCs are also associated with itch sensations elicited by immunologic and
non-immunologic stimulation.[4,5]Though of hematopoietic origin, MCs complete their differentiation into mature subsets
only after arriving in peripheral organs such as the skin, lung, and gut. MC density is
particularly abundant in skin.[6] The tissue
microenvironment shapes the developing MCs, as highlighted by the distinct phenotypes
developing in different tissues (broad distinction into MCT and
MCTC), and it is the tissue-specific niche that also maintains MC survival
after completion of their maturation process.[7]The developmental peculiarity of MCs vis-à-vis most other blood-borne cells
poses difficulty in obtaining pure, in situ differentiated MCs for research
purposes. To circumvent the problem, human MC research chiefly employs cells generated in
culture from hematopoietic progenitors with no contact to neighboring cells, connective
tissue and other elements of their in vivo habitat.[8,9,10,11,12] Our recent research activities within the FANTOM5 consortium
(Functional Annotation of the Mammalian Genome), highlighted, however, that tissue-derived
MCs progressively lose or modify key lineage attributes upon prolonged culture
vis-à-vis their counterparts ex vivo.[13,14,15]The regulation of fundamental cell fate decisions, such as death versus
survival, may likewise experience changes in non-natural surroundings, but such a
possibility has to our knowledge not been explored. A difference in survival properties
between MC subsets is, however, strengthened by a large body of evidence demonstrating
that MCs can differ regarding pro- and anti-apoptotic factors.[16,17,18,19,20,21,22,23,24]Here, we studied cell death regulation in skin MCs directly ex vivo. We report
that skin MCs exhibit substantial resistance to cell death even in the complete absence of
growth factors (GFs), whereas their cultured counterparts readily undergo cell death. In
search of the molecular underpinnings behind the difference, we reveal Mcl-1 as a key
factor imparting protection from mortality. Its vast expression within the cutaneous
habitat preserves MCs, likely contributing to their longevity.
Results
Skin MCs display relative resistance to cell death
Following recommendations from the NCCD (Nomenclature Committee on Cell
Death),[25] there is no single method to
unequivocally prove or disprove apoptosis or even general cell death, because each
method measures only a certain aspect and can produce false results if viewed in
isolation.To get a first insight into the kinetic order of events after the detachment of MCs
from their natural skin habitat, cells were kept in minimal medium in the absence of GF
and analyzed for signs of cell death by several methods. The results are specified in
the following paragraphs.
Cell size
Cell shrinkage is more commonly associated with apoptosis, whereas cells undergoing
necrotic cell death rather display swelling initially. The mean diameter of a foreskin
MC is ≈10.7 μm.[26,27] We monitored cell size
development upon transfer of purified skin MCs to minimal medium. As shown in Figure 1a, MCs slightly, but gradually decreased in size over
the 3-day-observation period.
Figure 1
Skin mast cells display relative resistance to cell death. Skin MCs ex vivo were kept
in GF/serum-free medium for up to 3 d. (a) cell size alteration over time (via
automatic cell counter), (b–e) percent of cells with (b)
externalized P-Serine (Annexin- V-FITC), (c) YoPro positivity, (d)
fragmented DNA (propidium iodide); (e) low mitochondrial membrane potential
(Depsipher); (f) caspase-3 activity (determined by Caspase-Glo 3/7 assay)
RLU=Relative Luminescence Units. Results represent the mean±S.E.M. of at least
three independent experiments.
Phosphatidylserine (P-Ser) externalization
P-Ser, a phospholipid membrane component, is confined to the inner side of the
membrane in healthy cells but can flip to the outer side in apoptotic cells, where it
becomes detectable by Annexin-V-FITC binding.[28] This method has frequently been employed to detect apoptosis in
cultured MCs.[10,18,22]Upon isolation, skin MCs regularly show a high degree of viability (for example,
≈99% trypan blue-negative),[29,30] as confirmed here by different methods
(Supplementary Figure 1).P-Ser externalization gradually increased over a 48 h observation period,
rising to ~25% at 24 h and 40% at 48 h (Figure
1b).
Alterations in plasma membrane properties
Apart from P-Ser externalization, apoptotic cells typically undergo further
morphologic and biochemical changes in membrane properties.[31] One method to capture this exploits the fact that the green
fluorescent YoPro-1 dye can permeate the slightly porous membrane of apoptotic cells.
Thus, the use of YoPro-1/PI enables visualization of P-Ser-independent membrane
alterations indicative of apoptosis. Here, the YoPro-1 signal increased
time-dependently, and ~20% of the MCs were YoPro-1-positive after 48 h (Figure 1c). Curve progression was comparable to Annexin-V-FITC
positivity (Figure 1b
versus
Figure 1c), but the proportion of cells stained by YoPro-1
was typically lower.
DNA degradation
We next addressed DNA degradation, a characteristic feature of apoptosis in its later
stage,[32] which can be visualized by
propidium iodide (PI) staining of cell nuclei to distinguish between diploid (viable)
and sub-diploid (apoptotic) DNA content.As shown in Figure 1d, nuclei displaying DNA degradation
increased in a constant but rather moderate fashion, reaching ~20% after 48 h.
Extending the time to 72 h resulted in a further increase to ≈25%.
Change in mitochondrial membrane potential
Mitochondria act as central gateway controllers of apoptosis particularly through the
release of pro-apoptotic factors into the cytoplasm.[33] Here, we investigated the electrochemical gradient disruption
across the mitochondrial inner membrane, which typically occurs during apoptotic cell
death. We used the Depsipher reagent, which aggregates in the mitochondria of healthy
cells to form an orange fluorescent compound, whereas it remains in its green form
when the MMP (mitochondrial membrane potential) is disrupted.The ratio of cells displaying MMP disturbance rose progressively for the first
24 h, when it reached a maximum of ≈22%, before declining to ≈10%
Depsipher-Green-positive cells after 48 h (Figure
1e).
Caspase-3 activity
Kinetic resolution of Caspase-3 activity revealed an increase during the first
12 h, followed by a plateau and eventually a slight decline (Figure 1f).Collectively, skin MCs ex vivo underwent progressive cell death in a
time-dependent fashion, and this was proven by different readouts. However, viable MCs
were still detectable after 72 h in the complete absence of specific GF and
serum, indicating protection of skin MCs from cell death.
Skin MCs can be induced to undergo rapid apoptosis
The resistance of skin MCs to death, revealed in the previous paragraph, raised the
question of whether these cells were susceptible to apoptosis induced by cues like
staurosporine, a well-known activator of caspase-mediated cell death.[34,35]Indeed, staurosporine led to a huge increment in cell death, and this was largely
consistent among detection methods (Figures 2a–e).
The proportion of apparently apoptotic MCs not only increased vis-à-vis
control but also reached remarkable global levels between 50 and 90% by all flow
cytometric methods, and there were barely any identifiable MCs left after 72 h.
YoPro-1 (Figure 2b) and DNA degradation (Figure 2c) had the highest increments over control, while the effect was
less pronounced for Annexin-V-FITC (Figure 2a). Caspase-3,
the actual indicator of responsiveness to staurosporine, showed a marked increase in
activity (Figure 2e).
Figure 2
Skin MCs can be induced to undergo rapid apoptosis. Skin MCs ex vivo were kept without
or with staurosporine (2 μM) in serum/GF-free medium for the
indicated times. (a–d) percent of cells with (a)
externalized P-Serine (Annexin-V-FITC), left side: representative flow cytometry dot
plots, right side: cumulative data of n=5 independent experiments, (b)
YoPro positivity, left side: representative flow cytometry dot plots, right side:
cumulative data of n=4 independent experiments, (c) fragmented DNA
(propidium iodide), left side: representative flow cytometry histograms, right side:
cumulative data of n=4 independent experiments, (d) low mitochondrial
membrane potential (Depsipher), left side: representative flow cytometry dot plots;
right side: cumulative data of n=4 independent experiments; (e)
caspase-3 activity (determined by Caspase-Glo 3/7 assay), cumulative data of
n=6 independent experiments, RLU=RLU=Relative Luminescence Units. Results
represent the mean±S.E.M. of n independent experiments;
*P<0.05, **P<0.01.
Collectively, we found that skin MCs can be forced to undergo cell death, indicating
that their apoptotic machinery was intact, but required a potent activator of
caspase-mediated death together with GF deprivation to affect a major proportion of the
population.
Stem cell factor (SCF) modestly counters apoptosis of ex vivo skin
MCs
SCF is arguably the most important mediator of MC survival.[36,37] We tested whether SCF would
protect skin MCs from death. As shown in Figure 3, SCF
significantly, yet modestly countered MC apoptosis. Again the results were largely
consistent among different methods (Figures
3a–e).
Figure 3
SCF modestly counters apoptosis of ex vivo skin MCs. Skin MCs ex vivo were kept without
or with SCF (10 ng/ml) in serum/GF-free medium for the indicated times.
(a–d) percent of cells with (a) externalized P-Serine
(Annexin-V-FITC), left side: representative flow cytometry dot plots, right side:
cumulative data of n=4 independent experiments, (b) YoPro positivity,
left side: representative flow cytometry dot plots, right side: cumulative data of
n=4 independent experiments, (c) fragmented DNA (propidium iodide),
left side: representative flow cytometry histograms, right side: cumulative data of
n=4 independent experiments, (d) low mitochondrial membrane potential
(Depsipher), left side: representative flow cytometry dot plots, right side: cumulative
data of n=4 independent experiments; (e) caspase-3 activity (determined
by Caspase-Glo 3/7 assay), cumulative data of n=6 independent experiments,
RLU=RLU=Relative Luminescence Units. Results represent the mean±S.E.M. of
n independent experiments; *P<0.05.
SCF was unable to revert the effect of staurosporine when applied before or together
with the caspase activator (data not shown), however, suggesting that the effect of
staurosporine was dominant.In summary, our data show that SCF protects skin MCs from cell death without fully
maintaining viability.
Cultured skin-derived MCs are more susceptible to cell death – more
pronounced rescue effects from SCF
SCF not only serves as survival factor of human MCs, but it can evoke cell
proliferation if used at high concentrations.[26,38] As expanded skin-derived MCs
differ from their ex vivo counterparts at multiple levels,[13,14] we addressed the
question of whether in-vitro expansion would modify MC susceptibility to cell
death, and this was indeed the case. In particular, cultured MCs displayed greater
proneness to cell death upon GF deprivation versus ex vivo MCs by different
methods (Figures 4a–c). Furthermore, the addition of
SCF 16 h prior to harvest resulted in a striking decrease in Annexin-V positivity
compared with the untreated control (Figure 4d).
Accordingly, there was a huge drop in sub-G1-nuclei (Figure
4e) and in caspase-3 activity (Figure 4f) in
SCF-treated cells vis-à-vis GF-deprived cells. Together, the data
suggested greater susceptibility of cultured than fresh skin MCs to apoptosis and a
greater rescue effect by SCF in the cultured system.
Figure 4
Cultured skin-derived MCs are more susceptible to cell death – more pronounced
rescue effects from SCF. (a–c) Long-term cultured skin-derived MCs
were exposed to GF/serum-free medium for a total of 40 h (white columns), ex
vivo skin MCs, shown for comparison, are as in Figure
2. (d–f) Long-term cultured skin-derived MCs were
pre-cultured in GF/serum-free medium for 16 h and supplied (or not) with SCF
(10 ng/ml) for 24 h (SCF-deficient conditions as in
a–c). Percent of cells with (a, d) externalized
P-Serine (Annexin-V-FITC), cumulative data of n=4 independent experiments,
(b, e) fragmented DNA (propidium iodide), left side: representative flow
cytometry histograms, right side: cumulative data of n=4 independent
experiments (c, f) caspase-3 activity (determined by Caspase-Glo 3/7
assay), cumulative data of n=4 independent experiments, RLU=Relative
Luminescence Units. Results represent the mean±S.E.M. of n independent
experiments; *P<0.05, **P<0.01.
Skin MCs ex vivo express abundant levels of the anti-apoptotic factor
Mcl-1
As skin MCs showed less susceptibility to apoptosis than their cultured equivalents
(Figures 1b–f
versus
Figures 4a and b), we set out to address the potential
protector(s), which impeded or delayed cell death in the natural MC subset. Because
Bcl-2 family members are crucially implicated in mitochondria-mediated apoptosis and
have been extensively studied in the lineage,[19,21,23,39-41] we
examined their expression in the two MC subsets benefitting from the recently available
FANTOM5 expression atlas. The atlas constitutes a comprehensive collection of nearly
1900 promoter-resolved transcriptomes from all sites of the human body, including MCs
from our laboratory both ex vivo and upon expansion in culture.[13,42] Of the
anti-apoptotic family members Mcl-1, Bcl-xL, Bcl-2, Bcl-2a1, and Bcl-2l2,
Mcl-1 was most abundant by far, and also most highly differential between ex
vivo and cultured MCs (9-fold higher in the former), while all other members were
comparable between subsets (Figure 5a). The latter was also
true for the four pro-apoptotic members of the Bcl-2 family (Bad, Bid, Bak, Bax) tested,
although there was a tendency for Bak and Bax to higher expression in cultured MCs
(Figure 5a).
Figure 5
Skin MCs ex vivo express abundant levels of the anti-apoptotic factor Mcl-1. Expression
of Bcl-2 family members by human skin-derived MCs ex vivo versus after long-term
expansion. (a) quantitative deep-CAGE sequencing analysis of mRNA encoding
members of the Bcl-2 family, presented in tags per million (from the FANTOM5 expression
atlas[12]), (b) quantitative RT-qPCR
analysis of mRNA encoding members of the Bcl-2 family, normalized to expression of the
housekeeping gene β-actin, cumulative data of n=5 independent
experiments. Results represent the mean±S.E.M. of n independent
experiments; *P<0.05, **P<0.01.
Using RT-qPCR, we validated the FANTOM5 deep sequencing data using multiple MC
preparations, obtaining a similar pattern (Figure 5b). In
particular Mcl-1 was confirmed as the most highly expressed Bcl-2 family member in MCs
ex vivo in our RT-qPCR panel, and it was likewise the most differential
family member among candidates (Figure 5b).Collectively, the comparative pattern of Bcl-2 family proteins made Mcl-1 the primary
candidate to explain the different susceptibility to apoptosis between freshly isolated
and long-term cultured skin MCs.
Mcl-1 imparts resistance of skin MC to cell death
Based on the above findings, we directly tested the hypothesis that Mcl-1 was
responsible for the resistance of skin MCs to apoptosis. Applying the recently
established technique of Accell mediated siRNA self-delivery to skin MCs,[29] we silenced Mcl-1 and monitored its impact on
survival. In fact, RNAi with Mcl-1-targeting siRNA resulted in accelerated cell decline,
as evidenced by a drop in MC recovery to only 33% (versus 55% upon
non-targeting siRNA) (Figure 6a). Accordingly, this was
accompanied by a decrease in Annexin-V-FITC/PI-double negative cells upon Mcl-1
knockdown (from 72% in the control to 57% – upon Mcl-1-directed siRNA) (Figure 6b).
Figure 6
Mcl-1 imparts resistance of skin MC to cell death. Impact of Mcl-1 silencing on MCs
after 48 h, evaluated by (a) cell number alteration (via automatic cell
counter), cumulative data of n=6 independent experiments, (b) percent of
cells with externalized P-Serine (Annexin-V-FITC), left side: representative flow
cytometry dot plots, right side: cumulative data of n=6 independent
experiments, (c, d) Mcl-1 knockdown confirmation (c) on mRNA level
by RT-qPCR, cumulative data of n=5 independent experiments, (d) on
protein level by western blot. Results represent the mean±S.E.M. of n
independent experiments; *P<0.05, ***P<0.005.
Verifying the efficiency of the technique, we found that the Mcl-1-targeting construct
indeed resulted in a strong decline in Mcl-1 gene expression compared with non-targeting
siRNA (Figure 6c), and this silencing gave rise to robust
decline in Mcl-1 protein (Figure 6d).Collectively, Mcl-1 silencing intensified MC susceptibility to cell death, suggesting a
crucial role of Mcl-1 in the protection of skin MCs from mortality.
Mcl-1 does not significantly contribute to the survival of skin-derived cultured
MCs and HMC-1
Since cultured skin-derived MCs displayed lower Mcl-1 expression (see Figure 5) and higher susceptibility to cell death compared with
freshly isolated skin MCs (see Figures 4a and b), we
hypothesized a minor effect of Mcl-1 in the former subset. Investigating this directly,
we found no effect of Mcl-1 siRNA on either cell recovery (Figure
7a) or the proportion of Annexin-V/PI-double negative cells (Figure 7b). The experiments were carried out in the presence of
SCF in order to be able to apply the technique (necessity of serum-free conditions).
Figure 7
Mcl-1 does not significantly contribute to the survival of skin-derived cultured MCs
and HMC-1. Impact of Mcl-1 silencing on (a–d) cultured skin-derived
MCs and (e–h) HMC-1 after 48 h, evaluated by
(a,e) cell number alteration (via automatic cell counter), cumulative
data of n=5 independent experiments, (b,f) percent of cells with
externalized P-Serine (Annexin-V-FITC), left side: representative flow cytometry dot
plots, right side: cumulative data of n=4 independent experiments; Mcl-1
knockdown confirmation (c,g) on mRNA level by RT-qPCR, cumulative data of
n=5 independent experiments, (d,h) on protein level by western
blot. Results represent the mean±S.E.M. of n independent experiments;
n.s.=not significant, *P<0.05.
We further used cells of the Human Mast Cell line-1 (HMC-1) cell line, a malignantly
transformed, highly immature MC line[38,43] as further model of (proliferating) MCs with the
result of complete resistance to alterations in Mcl-1 levels (Figures
7e and f).The lack of effect was not due to lower knockdown efficiency as both cultured
skin-derived as well as HMC-1 cells showed the same decrease of Mcl-1 mRNA as skin MCs
ex vivo (Figures 7c and g
versus
Figure 6c), and this was also true for the respective
protein product (Figures 7d and h
versus
Figure 6d).The combined data indicate that Mcl-1 is not implicated in the maintenance of
proliferating MCs, be it skin-derived be it malignantly transformed, in contrast to
natural skin MCs.
Discussion
MCs are believed to be long-lived and can survive even a lifetime, at least in the
mouse,[44,45,46] and there is great interest in
the factors establishing this longevity. Therefore, cell death regulation has been studied
under a variety of conditions in multiple MC subsets, but no study has to our knowledge
addressed the basic fitness of naturally differentiated, tissue-derived human MCs not
manipulated by prior culture.In the present study, we first proved that MCs from human dermis show remarkable survival
even in the absence of serum, SCF or any other GF. Protection from cell death was
illustrated by combining a variety of techniques, according to guidelines from the
NCCD.[47] The different methods revealed a
high degree of congruence, yet with distinct kinetics. The different time-courses were
according to expectation because the disruption of the mitochondrial membrane and
activation of caspase-3 are viewed as early events, whereas membrane alterations and
especially degradation of the DNA occur rather late in the apoptotic cascade.[31,48] Of the single-cell
methods employed, Annexin positivity was most pronounced throughout. This may be explained
by the fact that P-Ser externalization is not only a hallmark of apoptosis, but also
induced in other scenarios, for example, phagocytosis. Specifically in MCs, P-Ser becomes
transiently exposed upon activation.[49]
Therefore, the proportion of Annexin-staining cells may overestimate the real apoptotic
proportion. The transient increase in MMP with a rise up to 20% followed by a drop may be
explained by the timely elimination of cells displaying disrupted MMP. The same may apply
to the plateau observed for caspase-3 activity.Having uncovered that skin MCs are resistant to cell death even in the absence of GFs, we
sought to find the reason behind their remarkable fitness. Making use of staurosporine,
which bypasses the early events of apoptosis,[50]
we found that the compound readily induced apoptosis in skin MCs (Figure 2), suggesting that MC health was owed to a blocking event higher in
the hierarchy, that is, above caspase activation. This result also clarified that skin MCs
are not inherently resistant to apoptosis, for example, by hypoexpression of caspases, but
rather protected by (a) factor(s) upstream of caspases.SCF is arguably the most important GF of the lineage, influencing nearly all aspects of
MC biology, including chemotaxis, adhesion, phenotype, mediator production, and
stimulability by FcεRI aggregation, as it also potently counters MC
death.[36,51]
When investigating whether SCF prolonged skin MC survival, we indeed found a protective
yet rather modest effect (Figure 3), probably because baseline
survival was already pronounced.SCF is indispensable for culture of non-transformed human MCs, and can even trigger
proliferation at supra-physiological concentrations, leading to their
expansion.[13,14,26,52] We tested whether such skin-derived, but cultured MCs would react
more vigorously to SCF (after GF deprivation), and this was clearly the case (Figure 4). SCF’s potent anti-apoptotic effect detected for
cultured MCs is in accordance with multiple earlier studies with different types of
cultured MCs, where absence of survival factors provided the impetus for suicide, while
swift provision of SCF rescued MCs from mortality.[18,20,37]Strikingly, however, cultured MCs did not only show greater dependence on SCF for
survival, they also displayed a heightened proneness to cell death altogether (Figure 4). This difference could be excellently exploited to
pinpoint the factor(s) maintaining survival of ex vivo MC. From the impact of
staurosporine it was clear that MCs are able to undergo apoptosis if caspases are
activated, so that the block was expected to lie higher up in the hierarchy. Bcl-2 family
members are the key players regulating the mitochondrial pathway of
apoptosis.[19,21,23] We screened the FANTOM5
expression atlas for differences between skin MCs ex vivo and after
culture.[13]The majority of family members were either not differential or showed minor expression
only, for example, Bcl-2 itself. Conversely, Mcl-1 was revealed as the primary candidate
to explain the difference. It was abundantly expressed in MCs ex vivo, but much
less so in cultured MCs. It was also the most highly expressed family member whatsoever.
Validation of the deep sequencing data by RT-qPCR rendered comparable results, where Mcl-1
was also the only gene to significantly differ between the subsets. Therefore, Mcl-1
seemed an ideal candidate to explain the robustness of freshly isolated MCs.To evidence a role for Mcl-1, we employed the newly established technique for gene
knockdown in skin MCs,[29] a strategy that proved
that Mcl-1 was in fact imparting protection to skin MCs, thus aiding in their maintenance.
In contrast, it was of substantially less significance to both cultured MC subsets
employed. We conclude that in vivo matured, that is, natural skin MCs have both
higher expression of Mcl-1 than their cultured counterparts and greater reliance on Mcl-1
for their survival.Our current data fit the concept that death/survival decisions are mediated by different
sets of Bcl-2 members in each MC subset. For example, cultured human MCs (generated from
precursors or skin-derived) seem to require Bcl-xL for survival,[24] whereas necessities likewise differ between murine MMC-
and CTMC-like cells.[53] Because essential roles
of Bcl-2 and Bcl-xL were found in several studies for cultured, proliferating
MCs,[19,41] we
may speculate that Bcl-2 and Bcl-xL have essential roles in the process of MC
formation,[54] as well as in proliferative
MCs,[19,40]
whereas their roles vanish once MCs have completed differentiation and become quiescent in
terms of cell cycle progression.Support for this theory comes from evidence in the literature showing dependence of other
non-cycling immune cells on Mcl-1. An important example is long-lived plasma cells, for
which Mcl-1 was uncovered as the dominant survival factor, while plasma cell precursors
more strongly depended on Bcl-2 and Bcl-xL for survival.[55]In FANTOM5 highest expression of Mcl-1, in addition to (ex vivo) skin MCs, was
detected in granulocytes (neutrophils, eosinophils, basophils), which are end-stage
differentiation cells, and do not proliferate. In fact, an important role of Mcl-1 in the
prolongation of neutrophil survival has been extensively documented and
reviewed,[56] further supporting the notion
that Mcl-1 is a major contributor to survival of hematopoietic cells after their exit from
the cell cycle. In analogy to these other leukocytes, we surmise that the completion of MC
differentiation in skin depends on the accumulation of Mcl-1, whereas MCs at proliferative
stages depend less strongly on this factor. Mcl-1 function indeed depends on cellular
context and its knockdown can even increase sensitivity to apoptosis triggered by the
extrinsic route in tumor cells.[3]Interestingly, under circumstances of lysosomal destabilization, MCs seem to be prone to
apoptotic death.[57,58] The pathway may even preferentially occur in the lineage owing to
its high content of serglycin proteoglycans, yet it requires secretory granule
permeabilization and protease leakage into the cytoplasm as a trigger. It does not seem to
be spontaneously activated under homeostatic conditions, because MCs are long-lived in
their natural environment. In fact, elegant early studies revealed that MC survival in
skin was substantially prolonged vis-à-vis other leukocytes [45,46] even though it
remained unknown, how longevity is established. Our present data imply that in the absence
of lysosomal disruption,[57,58] it is the accumulation of Mcl-1 that, at least in part, bestows
this quality.In summary, we document that human skin MCs are equipped with baseline resistance to cell
death, surviving even harsh environmental conditions. Therefore, the skin provides a
milieu that supports the persistence of MCs, whereas liquid culture, despite
supra-physiological concentrations of SCF, does not fully mimic this micromilieu and gives
rise to MCs with altered properties.[13,14] Our results identify a critical role for Mcl-1 in the
maintenance of skin MCs. Forcing MCs into the cell cycle by saturating amounts of SCF
increases proneness to cell death, and concurrent rescue by SCF as it likewise diminishes
Mcl-1 expression and eliminates their dependence on this anti-apoptotic Bcl-2 member. We
propose that skin MC longevity, established by the MC-supportive niche of the dermis
surpasses SCF, and requires robust up-regulation of Mcl-1, which actively suppresses MC
demise.
Materials and methods
Purification of human skin MCs
MCs were isolated from human foreskin (circumcision), where typically material from
several donors was combined for one experiment. MCs from individual donors were also
used for confirmatory purposes for the majority of methods. The purification was
performed using an optimized and frequently employed protocol.[13,27,30,38],38In brief, human skin was cut into strips and treated with dispase (BD Biosciences,
Heidelberg, Germany) at 3.5 U/ml and 4 °C overnight. After removal of
the epidermis, the dermis was chopped into small pieces and digested with collagenase
type 1 at 10 mg/ml (Worthington, Lakewood, NJ, USA) for 1 h at
37 ° C. MC purification was achieved by positive selection with mouse
anti-humanc-Kit-coated microbeads and an Auto-MACS separation device (both from
Miltenyi Biotec, Bergisch Gladbach, Germany). MC purity consistently exceeded 98%, as
assessed by acidic toluidine-blue staining (0.1% in 0.5 N HCl).[29,30] Viability by trypan
blue exclusion was >99% and by flow cytometric methods between 93 and 95%
(Supplementary Figures A–C).
Determination of cell number and size
Cells were diluted 1:200 with Casy buffer and cell counting was accomplished
by the means of an automatic cell counter and analyzer (Casy Model TTC, Roche/Innovatis,
Mannheim, Germany). Mean cell diameter was quantified with the same device.Acquisition of particle diameter allowed distinguishing between cells with damaged and
intact membrane. The latter were considered as viable cells, and the cell number of this
fraction served to determine MC survival in % according to the following formula (final
cell count/plated cell count)×100.
Cell treatment
Skin MCs (~106 cells/well) were kept in minimal medium consisting of Basal
Iscove medium (with stable glutamine; Biochrom, Berlin, Germany), supplemented with 0.5%
BSA (Serva, Heidelberg, Germany). MCs were left untreated or stimulated with SCF
(Peprotech, Rocky Hill, CT, USA) (at 10 nM) or treated with staurosporine (Enzo
Life Sciences, Lörrach, Germany) (at 2 μM) for the indicated
times. After incubation, cells were washed with 1×Dulbecco's phosphate-buffered
saline (DPBS) (Thermo Fisher Science, Berlin, Germany) and processed for downstream
applications (as described below).
Long-term MC culture
For generating culture-expanded skin-derived MCs, freshly isolated skin MCs
(~5×105 cells/ml) were incubated in Basal Iscove medium, supplemented
with 10% FCS (Biochrom) and SCF (Peprotech) (at 100 ng/ml) to evoke
proliferation. Cell proliferation typically started after 6–8 weeks of
culture.[26,38,52]The HMC-1 (kindly provided by Dr JH Butterfield) was grown in Basal Iscove medium,
supplemented with 10% FCS.
Flow cytometric analysis of survival
Survival of human skin MCs were examined at the indicated times using several flow
cytometry based methods (described below). The stained cells were measured on a MACS
Quant FACS (Miltenyi Biotec) and analyzed using the FlowJo software (FlowJo LLC,
Ashland, OR, USA).
2.3.1. Annexin-V-FITC
Phosphadidylserine externalization was assessed using an Annexin-V-FITC Apoptosis
detection kit (eBioscience, San Diego, CA, USA) according to the manufacturer’s
instructions.By double-staining with Annexin-V-FITC and PI, subsets of cells that were
Annexin-V-positive and PI-negative (indicative of apoptosis) or Annexin-V-positive and
PI-positive (suggesting necrotic and/or cells in advanced apoptosis) were determined.
Annexin-V-FITC and PI-double negative cells were regarded as living.[33]
YoPro-1
Membrane porosity was examined using the Membrane Permeability/Dead Cell Apoptosis
Kit with YoPro-1 and PI (Invitrogen, Paisley, UK) in accordance with
the manufacturer’s instructions. Double-positive cells were considered necrotic
and/or cells in advanced apoptosis, whereas YoPro-1-positive and
PI-negative cells were regarded as apoptotic cells.
Propidium iodide
The percent of hypodiploid nuclei corresponding to cells with fragmented DNA were
determined by flow cytometric analysis after PI DNA staining. In brief, cells were
stained in 40 μg/ml PI (SigmaAldrich, Taufkirchen, Germany),
0.1% sodium citrate and 0.1% triton X-100 for 1 h at 4 °C and
analyzed by flow cytometry. Sub-G1 cell fractions correspond to cells with fragmented
DNA (indicating apoptosis).[59,60]
Depsipher MMP
The mitochondrial membrane potential was evaluated using Depsipher fluorescent
staining (R&D systems, Wiesbaden, Germany) according to the manufacturer’s
instructions, where slightly Depsipher-Green-positive and highly
Depsipher-Green-positive cells are considered apoptotic, whereas
Depsipher-Red-positive and Depsipher-Red/Green-double-positive cells are considered
viable.
Caspase-3 activity
Caspase-3 activity of MCs was detected, using a luminometric assay kit (Caspase-Glo
3/7; Promega, Mannheim, Germany) according to the manufacturer’s instructions.
The assay provides a proluminescent caspase-3/7 substrate, which contains the sequence
DEVD that is cleaved to release luminescence. The light detection was performed by means
of a microplate reader (Perkin Elmer, Berlin, Germany).
RT-quantitative PCR
RT-qPCR was performed as described.[38] In
brief, total RNA was isolated using the Nucleo spin RNA Kit (Macherey-Nagel, Düren,
Germany), and RT-qPCR was carried out with the LC Fast Start DNA Master SYBR Green kit
(Roche Applied-Science, Basel, Switzerland). The oligonucleotide primers (TIB Molbiol,
Berlin, Germany) were as follows:The expression levels of the target gene were quantified relative to the expression of
the reference gene β-actin using the 2-ΔΔCT method.
siRNA transfection
RNA interference in MCs was performed according to a recently established
protocol[29] using the Accell siRNA
Transfection Kit (Dharmacon Accell siRNA, GE Healthcare Dharmacon, Lafayette, CO, USA),
where MCs were transfected by gene-targeting siRNA or non-targeting siRNA. In brief, the
cells (~106 cells/well) were washed with 1×Accell siRNA Buffer and then
resuspended in Accell siRNA Delivery Medium and added to Accell siRNA Delivery Medium
containing 2 μM siRNA (Mcl-1-targeting or non-targeting) for a
final concentration of 1 μM and then incubated for 48 h. In
case of culture-expanded MCs, the transfection was carried out in the presence of SCF
(10 ng/ml). After incubation, cells were washed with 1× DPBS (Thermo Fisher
Science) and processed for downstream applications (see RT-qPCR, immunoblotting, cell
counting and Annexin-V-FITC staining).
Immunoblotting
MCs were lysed and separated through 12% SDS-PAGE.[29,38] After electrophoresis, the
proteins were transferred to nitrocellulose membranes. The membranes were blocked with
1× Casein Blocking Buffer (Sigma Aldrich, St Louis, MO, USA) and incubated with
primary (anti-Mcl-1 and anti-β-actin, each diluted
1 : 1000) antibodies (all from Cell Signaling Technologies, Danvers, MA,
USA) overnight and subsequently with (1 : 20 000 diluted) HRP
(horseradish peroxidase)-conjugated secondary antibodies (Merck Millipore, Darmstadt,
Germany) for 1.5 h. Finally, blots were visualized by a chemiluminesence assay
(Weststar Ultra 2.0, Cyanagen, Bologna, Italy) according to the manufacturer’s
instructions, and the bands were recorded using a detector for chemiluminesence (Fusion
FX7 Spectra, Vilber Lourmat, Eberhardzell, Germany).
Statistical analysis
Results are reported as mean±standard error of the mean (S.E.M.). Data were
statistically analyzed by the paired t-test (Figures
2, 3, 4a, 5b and 6c, d). The comparison of
Annexin-V positivity and caspase-3 activity in ex vivo MCs versus
cultured MCs was analyzed by the unpaired t-test (Figures 4a
and b). For the comparison of Mcl-1 mRNA expression in ex vivo MCs
versus cultured MCs the unpaired t-test was applied (Figure 5a). For normalized data the Wilcoxon matched-pairs signed
rank test was used (Figures 6a, 7a and
e). P-values<0.05 were considered statistically significant. Data
were analyzed with GraphPad Prism Version 6.01 Software (San Diego, CA, USA).
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps
and institutional affiliations.
Authors: Zane Orinska; Niko Föger; Michael Huber; Julia Marschall; Farhad Mirghomizadeh; Xin Du; Marina Scheller; Philip Rosenstiel; Torsten Goldmann; Annalena Bollinger; Bruce A Beutler; Silvia Bulfone-Paus Journal: Blood Date: 2010-07-01 Impact factor: 22.113
Authors: F Meggio; A Donella Deana; M Ruzzene; A M Brunati; L Cesaro; B Guerra; T Meyer; H Mett; D Fabbro; P Furet Journal: Eur J Biochem Date: 1995-11-15
Authors: Alistair R R Forrest; Hideya Kawaji; Michael Rehli; J Kenneth Baillie; Michiel J L de Hoon; Vanja Haberle; Timo Lassmann; Ivan V Kulakovskiy; Marina Lizio; Masayoshi Itoh; Robin Andersson; Christopher J Mungall; Terrence F Meehan; Sebastian Schmeier; Nicolas Bertin; Mette Jørgensen; Emmanuel Dimont; Erik Arner; Christian Schmidl; Ulf Schaefer; Yulia A Medvedeva; Charles Plessy; Morana Vitezic; Jessica Severin; Colin A Semple; Yuri Ishizu; Robert S Young; Margherita Francescatto; Intikhab Alam; Davide Albanese; Gabriel M Altschuler; Takahiro Arakawa; John A C Archer; Peter Arner; Magda Babina; Sarah Rennie; Piotr J Balwierz; Anthony G Beckhouse; Swati Pradhan-Bhatt; Judith A Blake; Antje Blumenthal; Beatrice Bodega; Alessandro Bonetti; James Briggs; Frank Brombacher; A Maxwell Burroughs; Andrea Califano; Carlo V Cannistraci; Daniel Carbajo; Yun Chen; Marco Chierici; Yari Ciani; Hans C Clevers; Emiliano Dalla; Carrie A Davis; Michael Detmar; Alexander D Diehl; Taeko Dohi; Finn Drabløs; Albert S B Edge; Matthias Edinger; Karl Ekwall; Mitsuhiro Endoh; Hideki Enomoto; Michela Fagiolini; Lynsey Fairbairn; Hai Fang; Mary C Farach-Carson; Geoffrey J Faulkner; Alexander V Favorov; Malcolm E Fisher; Martin C Frith; Rie Fujita; Shiro Fukuda; Cesare Furlanello; Masaaki Furino; Jun-ichi Furusawa; Teunis B Geijtenbeek; Andrew P Gibson; Thomas Gingeras; Daniel Goldowitz; Julian Gough; Sven Guhl; Reto Guler; Stefano Gustincich; Thomas J Ha; Masahide Hamaguchi; Mitsuko Hara; Matthias Harbers; Jayson Harshbarger; Akira Hasegawa; Yuki Hasegawa; Takehiro Hashimoto; Meenhard Herlyn; Kelly J Hitchens; Shannan J Ho Sui; Oliver M Hofmann; Ilka Hoof; Furni Hori; Lukasz Huminiecki; Kei Iida; Tomokatsu Ikawa; Boris R Jankovic; Hui Jia; Anagha Joshi; Giuseppe Jurman; Bogumil Kaczkowski; Chieko Kai; Kaoru Kaida; Ai Kaiho; Kazuhiro Kajiyama; Mutsumi Kanamori-Katayama; Artem S Kasianov; Takeya Kasukawa; Shintaro Katayama; Sachi Kato; Shuji Kawaguchi; Hiroshi Kawamoto; Yuki I Kawamura; Tsugumi Kawashima; Judith S Kempfle; Tony J Kenna; Juha Kere; Levon M Khachigian; Toshio Kitamura; S Peter Klinken; Alan J Knox; Miki Kojima; Soichi Kojima; Naoto Kondo; Haruhiko Koseki; Shigeo Koyasu; Sarah Krampitz; Atsutaka Kubosaki; Andrew T Kwon; Jeroen F J Laros; Weonju Lee; Andreas Lennartsson; Kang Li; Berit Lilje; Leonard Lipovich; Alan Mackay-Sim; Ri-ichiroh Manabe; Jessica C Mar; Benoit Marchand; Anthony Mathelier; Niklas Mejhert; Alison Meynert; Yosuke Mizuno; David A de Lima Morais; Hiromasa Morikawa; Mitsuru Morimoto; Kazuyo Moro; Efthymios Motakis; Hozumi Motohashi; Christine L Mummery; Mitsuyoshi Murata; Sayaka Nagao-Sato; Yutaka Nakachi; Fumio Nakahara; Toshiyuki Nakamura; Yukio Nakamura; Kenichi Nakazato; Erik van Nimwegen; Noriko Ninomiya; Hiromi Nishiyori; Shohei Noma; Shohei Noma; Tadasuke Noazaki; Soichi Ogishima; Naganari Ohkura; Hiroko Ohimiya; Hiroshi Ohno; Mitsuhiro Ohshima; Mariko Okada-Hatakeyama; Yasushi Okazaki; Valerio Orlando; Dmitry A Ovchinnikov; Arnab Pain; Robert Passier; Margaret Patrikakis; Helena Persson; Silvano Piazza; James G D Prendergast; Owen J L Rackham; Jordan A Ramilowski; Mamoon Rashid; Timothy Ravasi; Patrizia Rizzu; Marco Roncador; Sugata Roy; Morten B Rye; Eri Saijyo; Antti Sajantila; Akiko Saka; Shimon Sakaguchi; Mizuho Sakai; Hiroki Sato; Suzana Savvi; Alka Saxena; Claudio Schneider; Erik A Schultes; Gundula G Schulze-Tanzil; Anita Schwegmann; Thierry Sengstag; Guojun Sheng; Hisashi Shimoji; Yishai Shimoni; Jay W Shin; Christophe Simon; Daisuke Sugiyama; Takaai Sugiyama; Masanori Suzuki; Naoko Suzuki; Rolf K Swoboda; Peter A C 't Hoen; Michihira Tagami; Naoko Takahashi; Jun Takai; Hiroshi Tanaka; Hideki Tatsukawa; Zuotian Tatum; Mark Thompson; Hiroo Toyodo; Tetsuro Toyoda; Elvind Valen; Marc van de Wetering; Linda M van den Berg; Roberto Verado; Dipti Vijayan; Ilya E Vorontsov; Wyeth W Wasserman; Shoko Watanabe; Christine A Wells; Louise N Winteringham; Ernst Wolvetang; Emily J Wood; Yoko Yamaguchi; Masayuki Yamamoto; Misako Yoneda; Yohei Yonekura; Shigehiro Yoshida; Susan E Zabierowski; Peter G Zhang; Xiaobei Zhao; Silvia Zucchelli; Kim M Summers; Harukazu Suzuki; Carsten O Daub; Jun Kawai; Peter Heutink; Winston Hide; Tom C Freeman; Boris Lenhard; Vladimir B Bajic; Martin S Taylor; Vsevolod J Makeev; Albin Sandelin; David A Hume; Piero Carninci; Yoshihide Hayashizaki Journal: Nature Date: 2014-03-27 Impact factor: 49.962